Pemphigus Vulgaris - Pipeline Review, H1 2016 Featuring Almirall, Biogen, F. Hoffmann-La Roche, HanAll Biopharma, Immunomedics, Novartis & Principia Biopharma - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Pemphigus Vulgaris - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Pemphigus Vulgaris, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pemphigus Vulgaris and special features on late-stage and discontinued projects.

The report enhances decision-making capabilities and helps to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MoAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Pemphigus Vulgaris Overview
  3. Therapeutics Development
  4. Pipeline Products for Pemphigus Vulgaris - Overview
  5. Pipeline Products for Pemphigus Vulgaris - Comparative Analysis
  6. Pemphigus Vulgaris - Therapeutics under Development by Companies
  7. Pemphigus Vulgaris - Therapeutics under Investigation by Universities/Institutes
  8. Pemphigus Vulgaris Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Pemphigus Vulgaris - Products under Development by Companies
  13. Pemphigus Vulgaris - Products under Investigation by Universities/Institutes
  14. Pemphigus Vulgaris - Companies Involved in Therapeutics Development
  • Almirall, S.A.
  • Biogen, Inc.
  • F. Hoffmann-La Roche Ltd.
  • HanAll Biopharma Co., Ltd.
  • Immunomedics, Inc.
  • Novartis AG
  • Principia Biopharma Inc.

For more information visit http://www.researchandmarkets.com/research/llf76f/pemphigus

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Immune Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Immune Disorders Drugs